Evidence map›Paper›PMID 30339674›Full record

SynthesisPLoS neglected tropical diseases2018

Histoplasma capsulatum antigen detection tests as an essential diagnostic tool for patients with advanced HIV disease in low and middle income countries: A systematic review of diagnostic accuracy studies.

Mathieu Nacher, Denis Blanchet, Felix Bongomin, Arunaloke Chakrabarti, Pierre Couppié, Magalie Demar, David W Denning, Félix Djossou, Loïc Epelboin, Nelesh Govender and 13 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Genotypic diversity, virulence, and molecular genetic tools inMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Superiority of a Novel Mp1p Antigen Detection Enzyme Immunoassay Compared to Standard BACTEC Blood Culture in the Diagnosis of Talaromycosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. OccultOpen forum infectious diseases · 2020
    Article
  20. The global epidemiology of emergingStudies in mycology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 13 institutions in 8 countries.

Mathieu NacherCIC INSERM 1424, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana.ORCID 0000-0001-9397-3204
Denis BlanchetLaboratoire de parasitologie mycologie, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana.
Felix BongominGlobal Fund for Fungal Infections (GAFFI), Geneva, Switzerland.ORCID 0000-0003-4515-8517
Arunaloke ChakrabartiPostgraduate Institute of Medical Education & Research, Chandigarh, India.
Pierre CouppiéService de Dermatologie Vénéréologie, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana.
Magalie DemarLaboratoire de parasitologie mycologie, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana.
David W DenningGlobal Fund for Fungal Infections (GAFFI), Geneva, Switzerland.
Félix DjossouService des maladies infectieuses et tropicales, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana.
Loïc EpelboinService des maladies infectieuses et tropicales, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana.
Nelesh GovenderCentre for Opportunistic, Tropical and Hospital Infections, National Institute for Communicable Diseases (NICD), Johannesburg, South Africa.
Terezinha LeitãoUniversidade Federal do Ceará, Fortaleza, Brazil.
Sigrid Mac DonaldSRCS, Academic hospital Paramaribo, Paramaribo, Suriname.
Christine MandengueUniversité des Montagnes, Bangangté, Cameroon.
Silvia Helena Marques da SilvaEvandro Chagas Institute, Belem, Brazil.
Rita OladeleCollege of Medicine University of Lagos, Lagos, Nigeria.
Maria Mercedes PanizoInstituto Nacional de Higiene "Rafael Rangel", Caracas, Venezuela.
Alessandro PasqualottoUniversidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
Ruth RamosNational Care and Treatment Center, Georgetown, Guyana.
Subramanian SwaminathanGlobal Hospitals, Chennai, India.
Juan Luis Rodriguez-TudelaGlobal Fund for Fungal Infections (GAFFI), Geneva, Switzerland.
Stephen VredenSRCS, Academic hospital Paramaribo, Paramaribo, Suriname.
Rosely Zancopé-OliveiraFundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Antoine AdenisCIC INSERM 1424, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana.
Centre Hospitalier Andrée Rosemon · GFAcademic Hospital Paramaribo · SRFundação Oswaldo Cruz · BRGlobal Hospitals · INInstituto Evandro Chagas · BRInstituto Nacional de Higiene, Epidemiología y Microbiología · CUNational Institute for Communicable DiseasesPost Graduate Institute of Medical Education and Research · INUniversidade Federal de Ciências da Saúde de Porto Alegre · BRUniversidade Federal do Ceará · BRUniversité des Montagnes · CMUniversity of Guyana · GYUniversity of Lagos · NG

Funding

Medical Research Council MR/P017622/1
6 · The paper itself

Abstract

introductionDisseminated histoplasmosis, a disease that often resembles and is mistaken for tuberculosis, is a major cause of death in patients with advanced HIV disease. Histoplasma antigen detection tests are an important addition to the diagnostic arsenal for patients with advanced HIV disease and should be considered for inclusion on the World Health Organization Essential Diagnostics List.

objectiveOur objective was to systematically review the literature to evaluate the diagnostic accuracy of Histoplasma antigen tests in the context of advanced HIV disease, with a focus on low- and middle-income countries.

methodsA systematic review of the published literature extracted data on comparator groups, type of histoplasmosis, HIV status, performance results, patient numbers, whether patients were consecutively enrolled or if the study used biobank samples. PubMed, Scopus, Lilacs and Scielo databases were searched for published articles between 1981 and 2018. There was no language restriction.

resultsOf 1327 screened abstracts we included a total of 16 studies in humans for further analysis. Most studies included used a heterogeneousgroup of patients, often without HIV or mixing HIV and non HIV patients, with disseminated or non-disseminated forms of histoplasmosis. Six studies did not systematically use mycologically confirmed cases as a gold standard but compared antigen detection tests against another antigen detection test. Patient numbers were generally small (19-65) in individual studies and, in most (7/10), no confidence intervals were given. The post test probability of a positive or negative test were good suggesting that this non invasive diagnostic tool would be very useful for HIV care givers at the level of reference hospitals or hospitals with the infrastructure to perform ELISA tests. The first results evaluating point of care antigen detection tests using a lateral flow assay were promising with high sensitivity and specificity.

conclusionsAntigen detection tests are promising tools to improve detection of and ultimately reduce the burden of histoplasmosis mortality in patients with advanced HIV disease.

Indexed as

Antigens, FungalDeveloping CountriesDiagnostic Tests, RoutineEnzyme-Linked Immunosorbent AssayHistoplasmaHistoplasmosisHIV InfectionsHumansSensitivity and SpecificityAntigens, Fungal

Identifiers

PMID30339674
PMCPMC6209380
OpenAlexW2897992792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.